Showing results (111-120 of 124) with videos related to
Sort By:
Pageof 13
Gut|July 9, 2023
Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trialEvan S Dellon, Kathryn A Peterson, Benjamin L Mitlyng, et al.Nature Cell Biology|February 10, 2015
A high-throughput platform for stem cell niche co-cultures and downstream gene expression analysisAdam D Gracz, Ian A Williamson, Kyle C Roche, et al.Plos One|June 24, 2014
Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancerJohn M Carethers, Bhavya Murali, Bing Yang, et al.Molecular Metabolism|July 14, 2016
Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammationAmy R Johnson, Yuanyuan Qin, Alyssa J Cozzo, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2019
Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1Alex J Freemerman, Liyang Zhao, Ajeeth K Pingili, et al.Cancer Research|November 5, 2021
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and GrowthDanielle R Cook, Melissa Kang, Timothy D Martin, et al.Inflammatory Bowel Diseases|May 10, 2020
Natural History of Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort StudyBasavaraj Kerur, Eric I Benchimol, Karoline Fiedler, et al.The American Journal of Gastroenterology|March 6, 2024
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's DiseaseDawn R Ebach, Traci W Jester, Joseph A Galanko, et al.The American Journal of Gastroenterology|May 2, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.The American Journal of Gastroenterology|October 18, 2024
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.Pageof 13